Medical/Pharmaceuticals
ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company
BERLIN and CAIRO, May 27, 2021 /PRNewswire/ -- ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters inBerlin and access to a site in Cairo, which will house its principal manufacturing plant. The formation of MiGenTra accelerate...
2021-05-27 17:00
2094
Betagenon AB announces new CEO and new Chairman of the Board
STOCKHOLM, May 27, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced that James Hall BM, BCh, D.Phil has joined this month as CEO. Dr. Hall brings extensive senior healthcare and life science experience, including 12 yea...
2021-05-27 15:46
1204
Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision
DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /PRNewswire/ ...
2021-05-27 15:00
1215
Love Never Stops, Joining hands to care NMOSD patients across Asia and saying "NO" to relapse
BEIJING, May 27, 2021 /PRNewswire/ -- There is such a group of patients, who are at the golden age of their lives and should have been energetic students in the ivory tower, ladies braving the wind and waves in the workplace, or warm wives expecting at home … Their lives were full of hopes and dr...
2021-05-27 14:18
1795
Neteera makes annual CNBC Disruptor 50 list second year running
JERUSALEM, May 27, 2021 /PRNewswire/ -- Neteera
2021-05-27 09:00
1614
Gannex Received China IND Approval of Its FXR Agonist ASC42 for NASH Indication
SHANGHAI, May 27, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces that China National Medical Products Administration (NMP...
2021-05-27 08:30
2542
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered ...
2021-05-27 08:30
4770
Advanced Micro- and Nanofluidics to Revolutionize the Point-of-care Diagnostic Industry
With the COVID-19 outbreak rapidly decentralizing healthcare diagnostics, the use of microfluidics-based point-of-care diagnostic devices can provide higher accuracy, finds Frost & Sullivan SANTA CLARA, Calif., May 27, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Advanced Micro- and ...
2021-05-27 02:59
1270
Inteleos Announces MedGlobal and Global Ultrasound Institute as MissionPOCUS Selection for 2021
ROCKVILLE, Md., May 26, 2021 /PRNewswire/ -- The Point-of-Care Ultrasound (POCUS) Certification Academy under Inteleos announced a pilot project with MedGlobal and the Global Ultrasound Institute as the selection of their MissionPOCUS™ project for 2021. As the fourth MissionPOCUS project since th...
2021-05-26 23:36
1315
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China
SHANGHAI, May 26, 2021 /PRNewswire/ -- Luye Pharma Group announced today that its holding subsidiary, Boan Biotech, has signed an agreement with AstraZeneca China regarding the promotion rights to the anticancer drugBoyounuo® (Bevacizumab Injection), under which the former will grant to the latte...
2021-05-26 23:03
18486
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand
- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine DARMSTADT,...
2021-05-26 20:00
1938
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete RHB-107's ongoing Phase 2/3 study is enrolling U.S. non-hospitalized p...
2021-05-26 19:12
8800
IntoCare Medical Completes Up to 100 million RMB Round D Financing, Doubling Down on Powered Stapling Industry
SUZHOU, China, May 26, 2021 /PRNewswire/ -- IntoCare Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "IntoCare"), a global pioneer in Powered Surgical Staplers, today announced the completion of up to100 million RMB round D financing. Qiming Venture Partners led the investment w...
2021-05-26 12:20
2579
Texas Cardiac Arrhythmia Institute leader participates in clinical trial for catheter that may reduce complication risk during cardiac ablation
AUSTIN, Texas, May 26, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center participated in a clinical study to evaluate the safety and effectiveness of a new lattice sphere catheter designed to optimize procedural efficiency and efficacy ...
2021-05-26 10:13
2096
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)
- Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacin - Lefamulin was generally safe an...
2021-05-26 05:00
2058
Nanoform and Celanese Explore Ways to Enhance Drug Delivery
HELSINKI, May 25, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Celanese Corporation (NYSE: CE), a global specialty materials company, today announced plans to explore the synergies between their respective technologies in the field of nanop...
2021-05-25 21:45
1654
OptraSCAN Announces CytoSiA - A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing
- OptraSCAN's Intelligent Tool CytoSiA – To Advance Cytology Screening Through
Unmatched Image Quality And Artificial Intelligence Based Image Analysis
Solution
SAN JOSE, Calif. and PUNE, India, May 25, 2021 /PRNewswire/ -- OptraSCAN
2021-05-25 21:27
2486
Spinal Stabilization Technologies Ltd Earns CE Mark, FDA "Breakthrough Designation" For PerQdisc Nucleus Replacement System For Degenerative Disc Disease
KILKENNY, Ireland, May 25, 2021 /PRNewswire/ -- Spinal Stabilization Technologies, Ltd. (SST),Kilkenny, Ireland announced today that it has earned the CE Mark and the FDA's "breakthrough designation" for its PerQdisc™ Nucleus Replacement System. PerQdisc is the only commercially available lumbar...
2021-05-25 21:09
1913
Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite
SAN DIEGO, May 25, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it will soon open a high speed multi-purpose fill finish line in its state-of-the-art commercial manuf...
2021-05-25 20:05
1239
Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope
Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the...
2021-05-25 18:50
2475
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7862
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6955
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4242
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2819